Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Transcranial Magnetic Stimulation for the Treatment of Major Depression: Clinical, Economic, and Practical IssuesPart II

Demitrack, Mark A. MD

Section Editor(s): Janicak, Philip G. MD, Editor

doi: 10.1097/01.IDT.0000384050.93852.3e

Dr. Demitrack is Vice President and Chief Medical Officer, Neuronetics, Inc., 31 General Warren Boulevard, Malvern, PA 19355; E-mail:

Dr. Demitrack has disclosed that he is a stock shareholder in Pfizer and Lilly and is an employee of Neuronetics, Inc.

CME credit is not available with this article.

© 2010 Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website